A new study from Sweden suggests that semaglutide and liraglutide, commonly used to treat type 2 diabetes and obesity, reduce the risk of AUD-related hospitalizations more effectively than traditional AUD medications.
A new study indicates that users of glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and liraglutide have a significantly lower risk of being hospitalized due to alcohol use disorder (AUD) compared to those using traditional AUD medications. The research, conducted from 2006 to 2023 in Sweden and involving over 220,000 individuals with AUD, revealed that semaglutide users showed the lowest risk for AUD-related hospitalization (adjusted hazard ratio 0.64; 95% CI, 0.50-0.
83), followed by liraglutide users (aHR, 0.72; 95% CI, 0.57-0.92). The findings also suggest that these GLP-1 receptor agonists may be effective in reducing hospitalizations due to somatic conditions, though no significant association was found with suicide attempts
GLP-1 Receptor Agonists Semaglutide Liraglutide Alcohol Use Disorder Hospitalization Type 2 Diabetes Obesity SUD REWHARD Consortium
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Weight Loss Drugs Don’t Reduce Oocyte RetrievalWomen with varying exposure to GLP-1 agonists showed similar numbers of oocytes retrieved in controlled ovarian hyperstimulation.
Read more »
Obesity Week 2024 Tackles Treatment, Prevention and AccessAgenda features new trial results on GLP-1 agonists, along with obesity complications, obesity prevention starting in childhood, and improving access to obesity treatment.
Read more »
GLP-1 RAs Safe in the Perioperative Period: New GuidanceThe majority of patients may safely take glucagon-like peptide 1 receptor agonists before elective surgery and gastrointestinal endoscopies.
Read more »
Do Patients on Anti-Obesity Drugs Decrease Alcohol Use?Nearly half reported decreased drinking after initiating any anti-obesity medication, including second-generation GLP-1 receptor agonists.
Read more »
Diabetes medication may be effective in helping people drink less alcoholNew research has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use. The study looked at whether a type of diabetes medication, called GLP-1 receptor agonists (GLP-1 RAs), could also be used to help people cut down on drinking.
Read more »
AUD/USD: Above 0.6520, AUD to stop weakening furtherThe Australian Dollar (AUD) is expected to trade in a range between 0.6470 and 0.6520.
Read more »